Cancer Research is one of the most fields of work known to man. The disease itself has taking the lives of many people over the years despite having such great treatments. A of today there are many good treatments for fighting the disease, but Antibody Drug Conjugates takes the cake. ADCs are innovative in nature and far superior than treatments of the past. They are very effective at killing cancerous cells by the delivery of cell killing agents. This is a breakthrough in a sense, hints the name breakthrough based therapies. One of the leading companies for producing these advanced drugs are located in Bothell, Washington. Seattle Genetics is the name and eradicating cancer is the game. The company has grown into one of Puget Sounds largest employers with well over 800 employees on board. Of course every great company should have great leadership and Clay Siegall is the man of the hour.
Dr. Clay Siegall has a broad background in cancer research. He’s worked with many of the most prominent organizations such as The National Institute of Health, The National Cancer Institute, as well as Bristol Myers Squibb. This was well before the birth of Seattle Genetics. Dr. Siegall uses his broad educational background as the backbone of Seattle Genetics. Rigorous research, scientific innovation, and drug development are the main key factors for success. He also uses his Ph.D in Genetics for the greater good as well and it seems as if this guy just has no weaknesses. The good doctor is the holder of at least 15 patents and has written 70 successful publications throughout the years.
When it comes to raising capital look no further as Dr. Siegall has secured well over $1.2 Billion in private and public financing. Seattle Genetics is in great hands as it sits atop the hill and Dr. Clay Siegall is at the pinnacle of his game for cancer research.